PL2637704T4 - Radioznakowane ligandy oparte na fenyloimidazolu - Google Patents

Radioznakowane ligandy oparte na fenyloimidazolu

Info

Publication number
PL2637704T4
PL2637704T4 PL11791424T PL11791424T PL2637704T4 PL 2637704 T4 PL2637704 T4 PL 2637704T4 PL 11791424 T PL11791424 T PL 11791424T PL 11791424 T PL11791424 T PL 11791424T PL 2637704 T4 PL2637704 T4 PL 2637704T4
Authority
PL
Poland
Prior art keywords
phenylimidazole
radiolabelled
based ligands
ligands
radiolabelled phenylimidazole
Prior art date
Application number
PL11791424T
Other languages
English (en)
Other versions
PL2637704T3 (pl
Inventor
Jan Kehler
Benny Bang-Andersen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of PL2637704T4 publication Critical patent/PL2637704T4/pl
Publication of PL2637704T3 publication Critical patent/PL2637704T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
PL11791424T 2010-11-10 2011-11-10 Radioznakowane ligandy oparte na fenyloimidazolu PL2637704T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41193410P 2010-11-10 2010-11-10
DKPA201001023 2010-11-10
PCT/DK2011/000132 WO2012062319A1 (en) 2010-11-10 2011-11-10 Radiolabelled phenylimidazole-based ligands
EP11791424.2A EP2637704B9 (en) 2010-11-10 2011-11-10 Radiolabelled phenylimidazole-based ligands

Publications (2)

Publication Number Publication Date
PL2637704T4 true PL2637704T4 (pl) 2015-08-31
PL2637704T3 PL2637704T3 (pl) 2015-08-31

Family

ID=45098760

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11791424T PL2637704T3 (pl) 2010-11-10 2011-11-10 Radioznakowane ligandy oparte na fenyloimidazolu

Country Status (18)

Country Link
US (1) US8592449B1 (pl)
EP (1) EP2637704B9 (pl)
JP (1) JP5820887B2 (pl)
CN (1) CN103732260B (pl)
AU (1) AU2011328598B2 (pl)
CA (1) CA2817385A1 (pl)
DK (1) DK2637704T5 (pl)
ES (1) ES2539464T3 (pl)
HR (1) HRP20150560T2 (pl)
HU (1) HUE025511T2 (pl)
ME (1) ME02145B (pl)
PL (1) PL2637704T3 (pl)
PT (1) PT2637704E (pl)
RS (1) RS54039B1 (pl)
SG (1) SG190686A1 (pl)
SI (1) SI2637704T1 (pl)
SM (1) SMT201500139B (pl)
WO (1) WO2012062319A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790203B2 (en) 2012-11-26 2017-10-17 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
US20150313884A1 (en) 2013-01-15 2015-11-05 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists
JP6338223B2 (ja) * 2013-01-15 2018-06-06 ノバルティス アーゲー アルファ７ニコチン性アセチルコリン受容体アゴニストの使用
HK1210610A1 (en) * 2013-01-31 2016-04-29 霍夫曼-拉罗奇有限公司 Radiolabeled compounds
BR112020013820A2 (pt) 2018-11-06 2021-06-01 H. Lundbeck A/S inibidores de pde10a para tratamento de sintomas negativos e comprometimentos cognitivos em um paciente sofrendo de esquizofrenia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425548D0 (en) 2004-11-19 2004-12-22 Glaxo Group Ltd Radiolabelled ligands
ES2371927T3 (es) 2005-01-13 2012-01-11 Ge Healthcare Limited Compuestos de bencil-lactama marcados con 11c y su uso como agentes de obtención de imágenes.
WO2008020302A2 (en) 2006-08-17 2008-02-21 Pfizer Products Inc. Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
EP2036578A1 (en) 2007-09-13 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Diagnostic agents for positron emission imaging using F-18 radio labeled amino-alcohols
TWI501965B (zh) 2008-06-20 2015-10-01 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
EP2400991A1 (en) * 2009-02-24 2012-01-04 Janssen Pharmaceutica, N.V. Radiolabelled pde10 ligands

Also Published As

Publication number Publication date
HRP20150560T1 (xx) 2015-07-03
HUE025511T2 (en) 2016-04-28
PT2637704E (pt) 2015-07-21
HK1189498A1 (en) 2014-06-13
AU2011328598A1 (en) 2013-05-30
CA2817385A1 (en) 2012-05-18
JP5820887B2 (ja) 2015-11-24
JP2013543851A (ja) 2013-12-09
HRP20150560T2 (hr) 2015-11-20
SI2637704T1 (sl) 2015-07-31
DK2637704T5 (en) 2015-09-21
RS54039B1 (sr) 2015-10-30
EP2637704A1 (en) 2013-09-18
ES2539464T3 (es) 2015-07-01
AU2011328598B2 (en) 2016-04-21
WO2012062319A1 (en) 2012-05-18
US8592449B1 (en) 2013-11-26
ME02145B (me) 2015-10-20
EP2637704B1 (en) 2015-03-25
EP2637704B9 (en) 2015-08-05
DK2637704T3 (da) 2015-06-22
CN103732260A (zh) 2014-04-16
CN103732260B (zh) 2018-08-10
SG190686A1 (en) 2013-07-31
PL2637704T3 (pl) 2015-08-31
SMT201500139B (it) 2015-09-07
US20130303770A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
DK3342786T3 (en) Anti-dll3-antistof
IL221416A0 (en) Alpha-emititng complexes
AP3107A (en) 5-Alkynyl-pyrimidines
EP2566479A4 (en) AZA-INDAZOLES
EP2640189A4 (en) 3-deutero-pomalidomide
PT2585216T (pt) Complexos de п-alilpaládio e п-alilníquel para utilização como catalisadores em reações de acoplamento de carbono-carbono e carbono-azoto
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2516407A4 (en) RADIOPHARMACEUTICAL COMPLEXES
ZA201204448B (en) Heavy-duty axle-to-beam connection
EP2641891A4 (en) PKC ACTIVATOR-
GB2477915A8 (en) Carrier selection
IL219423A0 (en) Radiolabelled pde10 ligands
IL220850A0 (en) Pigmentation-preventing or-ameliorating agent
GB201003483D0 (en) Gold complexes
PL2637704T3 (pl) Radioznakowane ligandy oparte na fenyloimidazolu
GB201004151D0 (en) Luminophores
GB201010960D0 (en) Complex
GB0901231D0 (en) Ligands
GB201118411D0 (en) Not available
AU4536P (en) TB01 Tibouchina urvilleana
AU4822P (en) FlatwaxwhiteGL Chamelaucium uncinatum
AU4931P (en) FlatwaxDarkGL Chamelaucium uncinatum
AU4932P (en) FlatwaxpinkGL Chamelaucium uncinatum
AU4937P (en) FlatinsulGL Myoporum insulare
GB201014722D0 (en) Een